Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Telomir Pharmaceuticals Inc (NASDAQ: TELO) closed at $1.35 down -4.93% from its previous closing price of $1.42. In other words, the price has decreased by -$4.93 from its previous closing price. On the day, 1.83 million shares were traded. TELO stock price reached its highest trading level at $1.465 during the session, while it also had its lowest trading level at $1.34.
Ratios:
For a deeper understanding of Telomir Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.51 and its Current Ratio is at 17.51. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on February 21, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TELO now has a Market Capitalization of 46414312 and an Enterprise Value of 39178444.
Stock Price History:
The Beta on a monthly basis for TELO is -0.49, which has changed by -0.64141417 over the last 52 weeks, in comparison to a change of 0.15085125 over the same period for the S&P500. Over the past 52 weeks, TELO has reached a high of $7.08, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -7.69%, while the 200-Day Moving Average is calculated to be -42.66%.
Shares Statistics:
For the past three months, TELO has traded an average of 3.03M shares per day and 361580 over the past ten days. A total of 33.83M shares are outstanding, with a floating share count of 15.42M. Insiders hold about 55.16% of the company’s shares, while institutions hold 8.53% stake in the company. Shares short for TELO as of 1761868800 were 2279503 with a Short Ratio of 0.75, compared to 1759190400 on 1314090. Therefore, it implies a Short% of Shares Outstanding of 2279503 and a Short% of Float of 9.629999999999999.
Earnings Estimates
The market rating of Telomir Pharmaceuticals Inc (TELO) is currently shaped by the ongoing analysis conducted by 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.38 and -$0.38 for the fiscal current year, implying an average EPS of -$0.38. EPS for the following year is -$0.28, with 1.0 analysts recommending between -$0.28 and -$0.28.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $1.5M in the next fiscal year. The high estimate is $1.5M and the low estimate is $1.5M.
